Effects of curcuminoids on blood glucose, lipids, serum adipocyte fatty acid-binding protein and lipoprotein lipase in patients with type 2 diabetes: a double-blind, placebo-controlled trial

Public Health College - Harbin Medical University (China)0 个研究点目标入组 100 人开始时间: 2010年10月25日最近更新: 2022年5月30日

适应症

试验速览

2014 Results article in https://pubmed.ncbi.nlm.nih.gov/25374024/ (added 16/05/2022)

•1. Aged 18 - 65 years, both male and female
•2. Type 2 diabetes with fasting blood glucose greater than or equal to 7.0 mmol/L or postprandial blood glucose greater than or equal to 11.1 mmol/L
•3. Current optimal therapeutic regimens lasting for at least 6 months

•1. A history of type 1 diabetes, malignancies, thyroid or any other endocrine diseases likely to interfere with the study
•2. Diabetic ketosis acidosis and infection in recent 3 months
•3. Pregnancy or breastfeeding
•4. Information incompleted or unwillingness to attempt to comply with the intervention

发起方

Public Health College - Harbin Medical University (China)